Invasive Meningococcal Infection caused by Neisseria meningitidis serogroup Y
Also known as:Meningococcal Infection caused by Neisseria meningitidis serogroup Y
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB10061 | Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine | A conjugate vaccine used to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. |
| DB13888 | Meningococcal polysaccharide vaccine group Y | Meningococcal group Y polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup Y. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and... |
| DB10800 | Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen | Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup W-135. The vaccine... |
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Ph值ase | Status | Count |
|---|